BMEDIC ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  1.1% 1.0% 1.0% 1.8% 2.2%  
Credit score (0-100)  84 85 84 70 61  
Credit rating  BBB A A BBB BBB  
Credit limit (kDKK)  135.4 236.3 285.5 2.8 0.3  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  1,960 2,140 2,466 2,728 3,233  
EBITDA  757 846 764 1,324 1,697  
EBIT  744 837 757 1,324 1,697  
Pre-tax profit (PTP)  880.1 959.2 1,348.8 869.6 2,117.8  
Net earnings  684.1 748.1 1,052.1 676.7 1,647.2  
Pre-tax profit without non-rec. items  880 959 1,349 870 2,118  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  17.4 8.0 0.3 0.0 0.0  
Shareholders equity total  3,210 3,848 4,787 5,349 6,879  
Interest-bearing liabilities  56.8 49.7 92.7 103 111  
Balance sheet total (assets)  4,452 5,354 6,122 6,307 8,207  

Net Debt  -3,233 -3,508 -4,326 -4,270 -6,074  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,960 2,140 2,466 2,728 3,233  
Gross profit growth  -13.8% 9.2% 15.2% 10.6% 18.5%  
Employees  2 2 2 1 1  
Employee growth %  0.0% 0.0% 0.0% -50.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  4,452 5,354 6,122 6,307 8,207  
Balance sheet change%  12.7% 20.3% 14.3% 3.0% 30.1%  
Added value  757.0 846.3 764.3 1,331.6 1,697.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -26 -19 -15 -1 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  38.0% 39.1% 30.7% 48.5% 52.5%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  21.3% 19.9% 24.7% 26.8% 29.8%  
ROI %  29.8% 27.2% 32.2% 32.2% 34.8%  
ROE %  23.4% 21.2% 24.4% 13.4% 26.9%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  72.1% 71.9% 78.2% 84.8% 83.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -427.0% -414.5% -566.0% -322.4% -357.9%  
Gearing %  1.8% 1.3% 1.9% 1.9% 1.6%  
Net interest  0 0 0 0 0  
Financing costs %  17.8% 29.2% 94.8% 811.9% 44.9%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  3.1 3.0 3.7 5.5 5.3  
Current Ratio  3.6 3.6 4.6 6.6 6.2  
Cash and cash equivalent  3,289.4 3,557.6 4,418.9 4,372.6 6,184.9  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  586.2 619.1 1,128.6 2,228.6 3,377.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  379 423 382 1,332 1,697  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  379 423 382 1,324 1,697  
EBIT / employee  372 418 378 1,324 1,697  
Net earnings / employee  342 374 526 677 1,647